The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative Sciences & eXtellia, and his teams shared their scientific expertise in CRISPR/Cas9 technology and clinical development experience to the members in Corn lab.
Luca Bechter received his Bachelor’s degree in Biology from ETH Zurich in 2022. He is currently enrolled in the Biological Chemistry Master’s...
Irene received her MSc degree in Medical Biotechnology from the University of Modena and Reggio Emilia (Italy), where she worked on the characterization...
SWISSPR 2024 was a great success! Hosted by the Corn, Platt, Schwank and Jinek labs, we had a blast diving into the latest CRISPR research at the beautiful Seminarhotel...
Questions and/or comments about Corn Lab and its activities may be addressed to:
